European Medicines Agency's workshop on stem cell-based therapies
Date:
10/05/2010
Location:
London, UK
The European Medicines Agency together with the Committee for Advanced Therapies(CAT), the Cell Product Working Party (CPWP) and the Biologics Working Party (BWP) held a workshop to discuss the state-of-the-science on stem cell-based therapies.
-
List item
Summary report on the EMA workshop on stem cellbased therapies (PDF/179.81 KB)
First published: 01/07/2010
Last updated: 01/07/2010
EMA/319294/2010 -
List item
Agenda - Workshop on stem cell-based therapies (PDF/95.64 KB)
Draft
First published: 23/04/2010
Last updated: 23/04/2010
EMA/CAT/80413/2010 -
List item
EU Support for Stem Cell Research, Dr Charles Kessler, EC DG Research (PDF/344.5 KB)
First published: 12/05/2010
Last updated: 12/05/2010 -
List item
Human Embryonic Stem Cells: Considerations for Therapeutic Product Development, Dr Jane S. Lebkowski, Geron Corporation (PDF/578.84 KB)
First published: 12/05/2010
Last updated: 12/05/2010 -
List item
Induced pluripotent stem cells: Prof Marc Peschanski, I-stem, Evry, France (PDF/1.73 MB)
First published: 12/05/2010
Last updated: 12/05/2010 -
List item
Mesenchymal stem cells - Science and therapeutic applications: Dr Dirk Buscher, Grifols (PDF/1.56 MB)
First published: 12/05/2010
Last updated: 12/05/2010 -
List item
Haematopoietic stem cells: Dr Neil Rodrigues, NIH Centre of Biomedical Research Excellence in Tissue Repair and Stem Cells, USA (PDF/791.03 KB)
First published: 12/05/2010
Last updated: 12/05/2010 -
List item
Neural stem cells: Prof Gianvito Martino, Division of Neuroscience San Raffaele Hospital, Italy (PDF/4.7 MB)
First published: 12/05/2010
Last updated: 12/05/2010 -
List item
Stem cell-based medicinal products as ATMPs in the EU: Dr Paula Salmikangas (PDF/1.03 MB)
First published: 12/05/2010
Last updated: 12/05/2010 -
List item
Stem cell-based medicinal products as ATMPs in the EU: Dr Tiina Palomà¤ki (PDF/313.64 KB)
First published: 12/05/2010
Last updated: 12/05/2010 -
List item
Overview of Regulation of Stem Cell-based products by the USA FDA: Dr Kimberly Benton, Division of Cellular and Gene Therapies, Office for Cellular, Tissue and Gene Therapy, CBER, FDA (PDF/178.25 KB)
First published: 12/05/2010
Last updated: 12/05/2010